High acquisition and environmental contamination rates of CC17 ampicillin-resistant Enterococcus faecium in a Dutch hospital
Author(s) -
Marieke J. A. de Regt,
L. E. van der Wagen,
Janetta Top,
Hetty E. M. Blok,
Titia E. M. Hopmans,
A. W. Dekker,
Ronald J. Hené,
Peter D. Siersema,
Rob J. L. Willems,
Marc J. M. Bonten
Publication year - 2008
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkn390
Subject(s) - enterococcus faecium , ampicillin , enterococcus , contamination , microbiology and biotechnology , medicine , vancomycin resistant enterococcus , antibiotics , vancomycin , environmental health , biology , bacteria , staphylococcus aureus , ecology , genetics
Enterococcus faecium has rapidly emerged as a nosocomial pathogen worldwide, and the majority of these isolates belong to clonal complex-17 (CC17). In Europe, CC17 isolates are usually ampicillin-resistant, but most are still vancomycin-sensitive. We aimed to study ampicillin-resistant E. faecium (ARE) epidemiology in our hospital.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom